For research use only. Not for therapeutic Use.
GN25（Cat No.:M013899）is a potent, selective inhibitor targeting key enzymes involved in inflammatory pathways, specifically designed for the treatment of inflammatory and autoimmune diseases. It works by modulating the immune response, reducing excessive inflammation, and preventing tissue damage associated with chronic conditions. GN25 has shown significant promise in preclinical studies for conditions such as rheumatoid arthritis, lupus, and inflammatory bowel disease (IBD). Its mechanism of action focuses on inhibiting specific molecules involved in immune cell activation and cytokine production, offering a potential therapeutic option for patients with debilitating inflammatory diseases.
| CAS Number | 1227401-27-5 |
| Synonyms | 3-(5,8-dimethoxy-1,4-dioxonaphthalen-2-yl)sulfanylpropanoic acid |
| Molecular Formula | C15H14O6S |
| Purity | ≥95% |
| IUPAC Name | 3-(5,8-dimethoxy-1,4-dioxonaphthalen-2-yl)sulfanylpropanoic acid |
| InChI | InChI=1S/C15H14O6S/c1-20-9-3-4-10(21-2)14-13(9)8(16)7-11(15(14)19)22-6-5-12(17)18/h3-4,7H,5-6H2,1-2H3,(H,17,18) |
| InChIKey | DIIRLGMLDOPLPV-UHFFFAOYSA-N |
| SMILES | COC1=C2C(=O)C=C(C(=O)C2=C(C=C1)OC)SCCC(=O)O |
